Skip to content

Author

A. Bourdin

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Tracking blood eosinophils over time: long-term trends in asthmatic patients from the COBRA cohort.

BACKGROUND In patients with asthma, long-term follow-up of blood eosinophil count (BEC) may be useful for identifying endotypes. The observational French COhort of BRonchial obstruction and Asthma (COBRA) study is an observational prospective multicenter cohort enrolling asthmatic patients. OBJECTIVE To compare clini...

M. Gueçamburu, Fanchon Herman, Joana Vitte et al. · 0 citations
Open access Oct 2026

Sustained low disease activity during long-term mepolizumab treatment in FIP1L1::PDGFRA-negative hypereosinophilic syndrome: a multicenter real-world study.

Mepolizumab provided sustained long-term disease control with low glucocorticoid exposure in FIP1L1::PDGFRA-negative HES and EoLDAS offers a pragmatic measure of longitudinal disease control that warrants prospective validation and may inform future treat-to-target strategies.

K. Chevalier, François Barde, S. Faguer et al. · 0 citations
Review Open access Sep 2026

Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP.

RATIONALE The efficacy of biologics remains debatable in current or ex- smokers with severe asthma. OBJECTIVES This study aimed to evaluate responses to biologics by smoking exposure and to assess variations in management practice across Europe. METHODS This was a retrospective real-world study of adults with sever...

M. Caminati, J. Charriot, A. Bansal et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.